Amber H. Fradkin, Ph.D.
Affiliations: | 2009 | Chemical Engineering | University of Colorado, Boulder, Boulder, CO, United States |
Area:
Chemical Engineering, ImmunologyGoogle:
"Amber Fradkin"Parents
Sign in to add mentor| Theodore W. Randolph | grad student | 2009 | CU Boulder | |
| (Immunogenicity of therapeutic proteins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rech J, Fradkin A, Krueger A, et al. (2020) Evaluation of Particle Techniques for the Characterization of Subvisible Particles From Elastomeric Closure Components. Journal of Pharmaceutical Sciences. 109: 1725-1735 |
| Krueger AB, Hadley J, Cheney PP, et al. (2018) Application of a best practice approach using Resonant Mass Measurement for Biotherapeutic Product Characterization. Journal of Pharmaceutical Sciences |
| Fradkin AH, Mozziconacci O, Schöneich C, et al. (2014) UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 87: 395-402 |
| Fradkin AH, Carpenter JF, Randolph TW. (2011) Glass particles as an adjuvant: a model for adverse immunogenicity of therapeutic proteins. Journal of Pharmaceutical Sciences. 100: 4953-64 |
| Fradkin AH, Boand CS, Eisenberg SP, et al. (2010) Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure. Biotechnology Progress. 26: 743-9 |
| Fradkin AH, Carpenter JF, Randolph TW. (2009) Immunogenicity of aggregates of recombinant human growth hormone in mouse models. Journal of Pharmaceutical Sciences. 98: 3247-64 |